LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35

Search options

  1. Article: Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases.

    Fortea, José Ignacio / Puente, Ángela / Crespo, Javier / Fábrega, Emilio

    Hepatobiliary surgery and nutrition

    2023  Volume 12, Issue 1, Page(s) 105–109

    Language English
    Publishing date 2023-01-16
    Publishing country China (Republic : 1949- )
    Document type Editorial ; Comment
    ZDB-ID 2812398-0
    ISSN 2304-389X ; 2304-3881
    ISSN (online) 2304-389X
    ISSN 2304-3881
    DOI 10.21037/hbsn-22-556
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Cirrhosis, a Global and Challenging Disease.

    Fortea, José Ignacio / Crespo, Javier / Puente, Ángela

    Journal of clinical medicine

    2022  Volume 11, Issue 21

    Abstract: Cirrhosis is the result of sustained liver damage leading to the diffusion of hepatic fibrosis, wherein the normal hepatic architecture is replaced by abnormally organized nodules separated by fibrous septa that connect the different vascular structures ... ...

    Abstract Cirrhosis is the result of sustained liver damage leading to the diffusion of hepatic fibrosis, wherein the normal hepatic architecture is replaced by abnormally organized nodules separated by fibrous septa that connect the different vascular structures of the hepatic lobule [...].
    Language English
    Publishing date 2022-11-02
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11216512
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A Rare But Recognizable Cholestatic Liver Disease.

    Ezcurra, Iranzu / Fortea, José Ignacio / Crespo, Javier

    Gastroenterology

    2018  Volume 155, Issue 3, Page(s) e17–e19

    MeSH term(s) Adult ; Cholelithiasis/complications ; Cholestasis, Intrahepatic/etiology ; Humans ; Male ; Phospholipids/deficiency ; Syndrome
    Chemical Substances Phospholipids
    Language English
    Publishing date 2018-04-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2018.04.023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Ectopic variceal bleeding secondary to porto-sinusoidal vascular disease.

    Antón RodrÍguez, Ángela / Puente Sánchez, Ángela María / Fortea, José Ignacio / Odriozola Herrán, Aitor / Echavarría Rodríguez, Víctor José / Alonso Fernández, Sara / Montano Lumbreras, Elena

    Revista espanola de enfermedades digestivas

    2023  

    Abstract: Porto-sinusoidal vascular disease (PSVD) is an uncommon cause of portal hypertension (PHT) characterized by typical manifestations of PHT in the absence of an identifiable cause such as cirrhosis or splenoportal thrombosis (1). There are different ... ...

    Abstract Porto-sinusoidal vascular disease (PSVD) is an uncommon cause of portal hypertension (PHT) characterized by typical manifestations of PHT in the absence of an identifiable cause such as cirrhosis or splenoportal thrombosis (1). There are different etiological factors, including oxaliplatin (2). We present the case of a 67-year-old male with a history of locally advanced rectal cancer in 2007 treated with chemotherapy (capecitabine, folinic acid, 5-fluorouracil and oxaliplatin), radiotherapy and surgery with a definitive colostomy. He was admitted for lower gastrointestinal bleeding from the colostomy with no anemia or hemodynamic repercussion. Colonoscopy was performed and no lesions were found. Abdominal computed tomography (CT) showed peristomal varices with porto-systemic collaterals at that level. There was splenomegaly, no evidence of chronic liver disease and the splenoportal axis was permeable. Laboratory tests showed chronic thrombocytopenia. Laboratory results excluded other causes of liver disease, hepatic elastography showed a value of 7.2 kPa and upper gastrointestinal endoscopy ruled out esophagogastric varices. The catheterisation of hepatic veins demonstrated a hepatic venous pressure gradient of 13.5 mmHg and liver biopsy revealed sinusoidal dilatation with sinusoidal and perivenular fibrosis. Because of the clinical context of the patient with a history of treatment with oxaliplatin, he was diagnosed with peristomal ectopic varices secondary to porto-sinusoidal vascular disease. Due to bleeding recurrence, it was finally decided to place a transjugular intrahepatic portosystemic shunt (TIPS).
    Language English
    Publishing date 2023-06-14
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 1070381-0
    ISSN 1130-0108 ; 0212-7512
    ISSN 1130-0108 ; 0212-7512
    DOI 10.17235/reed.2023.9683/2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients.

    Cuadrado, Antonio / Fortea, José Ignacio / Rodríguez-Lope, Carlos / Puente, Ángela / Fernández-Vilchez, Vanesa / Echavarria, Victor Jose / Castillo Suescun, Federico José / Fernández, Roberto / Echeverri, Juan Andrés / Achalandabaso, Mar / Toledo, Enrique / Pellón, Raúl / Rodríguez Sanjuan, Juan Carlos / Crespo, Javier / Fábrega, Emilio

    Journal of clinical medicine

    2023  Volume 12, Issue 17

    Abstract: Liver transplantation (LT) is a curative treatment for early-stage hepatocellular carcinoma (HCC) unsuitable for surgical resection. However, tumor recurrence (TR) rates range from 8% to 20% despite strict selection criteria. The validation of new ... ...

    Abstract Liver transplantation (LT) is a curative treatment for early-stage hepatocellular carcinoma (HCC) unsuitable for surgical resection. However, tumor recurrence (TR) rates range from 8% to 20% despite strict selection criteria. The validation of new prognostic tools, such as pre-MORAL or RETREAT risks, is necessary to improve recurrence prediction. A retrospective study was conducted at Marqués de Valdecilla University Hospital in Cantabria, Spain, between 2010 and 2019 to determine the rate of TR in LT patients and identify associated factors. Patients with liver-kidney transplantation, re-transplantation, HIV infection, survival less than 90 days, or incidental HCC were excluded. Data on demographic, liver disease-related, LT, and tumor-related variables, as well as follow-up records, including TR and death, were collected. TR was analyzed using the Log-Rank test, and a multivariate Cox regression analysis was performed. The study was approved by the IRB of Cantabria. TR occurred in 13.6% of LT patients (95% CI = 7.3-23.9), primarily as extrahepatic recurrence (67%) within the first 5 years (75%). Increased TR was significantly associated with higher Body Mass Index (BMI) (HR = 1.3 [95% CI = 1.1-1.5]), vascular micro-invasion (HR = 8.8 [1.6-48.0]), and medium (HR = 20.4 [3.0-140.4]) and high pre-MORAL risk (HR = 30.2 [1.6-568.6]). TR also showed a significant correlation with increased mortality. Conclusions: LT for HCC results in a 13.6% rate of tumor recurrence. Factors such as BMI, vascular micro-invasion, and medium/high pre-MORAL risk are strongly associated with TR following LT.
    Language English
    Publishing date 2023-08-23
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12175457
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: No evidence of association between inherited thrombophilia and increased risk of liver fibrosis.

    Ezcurra, Iranzu / Puente, Ángela / Cuadrado, Antonio / Tamayo, Ibai / Iruzubieta, Paula / Arias-Loste, María Teresa / González, Francisco José / Pellón, Raúl / Sánchez, Sara / Crespo, Juan / Acebo, Mercedes / López-Hoyos, Marcos / Pérez, Rocío / Cuesta, Amalia / Antón, Ángela / Echavarría, Víctor / Fábrega, Emilio / Crespo, Javier / Fortea, Jose Ignacio

    United European gastroenterology journal

    2023  Volume 11, Issue 10, Page(s) 1010–1020

    Abstract: Background: Preliminary evidence suggests that inherited hypercoagulable disorders can lead to an increased risk of significant liver fibrosis.: Objective: We aimed to investigate the prevalence of significant fibrosis in patients with inherited ... ...

    Abstract Background: Preliminary evidence suggests that inherited hypercoagulable disorders can lead to an increased risk of significant liver fibrosis.
    Objective: We aimed to investigate the prevalence of significant fibrosis in patients with inherited thrombophilia, assessed by using liver stiffness (LS), and to compare this prevalence to that found in a large population-based cohort from the same region.
    Methods: This was a single-center, cross-sectional study. A complete laboratory analysis for liver disease, LS by transient elastography and an abdominal ultrasound were performed in patients with inherited thrombophilia diagnosed between May 2013-February 2017. These patients were propensity score matched (ratio 1:4) with a population-based cohort from the same region (PREVHEP-ETHON study; NCT02749864; N = 5988).
    Results: Of 241 patients with inherited thrombophilia, eight patients (3.3%) had significant fibrosis (LS ≥8 kPa). All of them had risk factors for liver disease and met diagnostic criteria for different liver diseases. After matching 221 patients with thrombophilia with 884 patients of the PREVHEP-ETHON cohort, the prevalence of significant fibrosis was similar between both cohorts (1.8% vs. 3.6%, p = 0.488). Multivariate analysis showed that age and liver disease risk factors, but not belonging to the thrombophilia cohort, were associated with the presence of significant fibrosis. The magnitude of the increased risk of significant fibrosis in patients with risk factors for liver disease was also similar in both cohorts.
    Conclusions: Our findings do not provide evidence supporting an association between inherited thrombophilia and an increased risk of significant liver fibrosis, independent of the presence of liver-related causes of fibrosis.
    MeSH term(s) Humans ; Cross-Sectional Studies ; Liver Cirrhosis/diagnosis ; Liver Diseases/complications ; Thrombophilia/complications ; Thrombophilia/epidemiology ; Thrombophilia/genetics
    Language English
    Publishing date 2023-11-28
    Publishing country England
    Document type Clinical Study ; Journal Article
    ZDB-ID 2728585-6
    ISSN 2050-6414 ; 2050-6406
    ISSN (online) 2050-6414
    ISSN 2050-6406
    DOI 10.1002/ueg2.12500
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review.

    Odriozola, Aitor / Puente, Ángela / Cuadrado, Antonio / Rivas, Coral / Anton, Ángela / González, Francisco José / Pellón, Raúl / Fábrega, Emilio / Crespo, Javier / Fortea, José Ignacio

    Journal of clinical medicine

    2022  Volume 11, Issue 21

    Abstract: Portal vein thrombosis constitutes the most common thrombotic event in patients with cirrhosis, with increased rates in the setting of advanced liver disease. Despite being a well-known complication of cirrhosis, the contribution of portal vein ... ...

    Abstract Portal vein thrombosis constitutes the most common thrombotic event in patients with cirrhosis, with increased rates in the setting of advanced liver disease. Despite being a well-known complication of cirrhosis, the contribution of portal vein thrombosis to hepatic decompensation and overall mortality is still a matter of debate. The incorporation of direct oral anticoagulants and new radiological techniques for portal vein recanalization have expanded our therapeutic arsenal. However, the lack of large prospective observational studies and randomized trials explain the heterogenous diagnostic and therapeutic recommendations of current guidelines. This article seeks to make a comprehensive review of the pathophysiology, clinical features, diagnosis, and treatment of portal vein thrombosis in patients with cirrhosis.
    Language English
    Publishing date 2022-10-30
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11216435
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave?

    Odriozola, Aitor / San Segundo, David / Cuadrado, Antonio / Hernáez, Tania / Escrich, Víctor / Fortea, José Ignacio / Martínez, Ángela / Puente, Ángela / Lapeña, Berta / Del Barrio, María / López-Hoyos, Marcos / Crespo, Javier / Fábrega, Emilio

    Transplantation

    2022  Volume 106, Issue 7, Page(s) 1445–1449

    Abstract: Background: Since the declaration of a new variant of concern (VOC), Omicron, by the World Health Organization in November 2021, a quick spread has been documented worldwide, being the main VOC in the sixth wave in Spain. The Omicron variant has more ... ...

    Abstract Background: Since the declaration of a new variant of concern (VOC), Omicron, by the World Health Organization in November 2021, a quick spread has been documented worldwide, being the main VOC in the sixth wave in Spain. The Omicron variant has more transmissibility, lower virulence, and less risk of severe disease than previously described VOC. Here we analyze the current wave of severe acute respiratory syndrome coronavirus 2 infection in liver transplant recipients (LTRs).
    Methods: A retrospective observational study of 355 LTRs was conducted in La Rioja and Cantabria regions of Spain. Epidemiological and clinical parameters were gathered on the basis of clinical records and telephone interviews.
    Results: In the current wave of infection, a higher number of LTRs have been found to be infected than the sum of the previous 5 waves (30 versus 16 LTRs). Of the 30 infected LTRs, 29 (96.6%) had received 3 vaccine doses (mRNA based), in a median of 93 d (interquartile range, 86-108) before infection. Eight of 30 LTRs (24.0%) were asymptomatic and 21 LTRs (67.8%) were with mild symptoms with a mean duration of 4.6 d (interquartile range, 2.5-7), whereas in the unvaccinated LTRs, the symptoms were fever, nausea, vomiting, and diarrhea. Moreover, in the sixth wave, intrafamiliar transmission was the main route of infection (17/30; 56.6%), and nosocomial transmission was confirmed in 2 LTRs (6.6%).
    Conclusions: In our series, increased transmissibility of the Omicron variant was confirmed, including nosocomial infection, with a lower risk of severe disease in LTRs. These findings could be supported by the universal vaccination of LTRs and less virulence of the Omicron variant.
    MeSH term(s) COVID-19/epidemiology ; COVID-19/transmission ; COVID-19 Vaccines/administration & dosage ; Humans ; Liver Transplantation ; SARS-CoV-2 ; Spain/epidemiology ; Vaccination
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2022-04-08
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 208424-7
    ISSN 1534-6080 ; 0041-1337
    ISSN (online) 1534-6080
    ISSN 0041-1337
    DOI 10.1097/TP.0000000000004157
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: An Elusive Diagnosis in Noncirrhotic Chronic Portal Vein Thrombosis.

    Fortea, José Ignacio / Puente, Angela / Cuadrado, Antonio / Del Pozo, Carmen / García, Inés / Pellon, Raul / Cagigal, Maria Luisa / Fábrega, Emilio / Crespo, Javier

    The American journal of medicine

    2020  Volume 134, Issue 3, Page(s) e199–e200

    MeSH term(s) Aged ; Chronic Disease ; Humans ; Male ; Portal Vein ; Venous Thrombosis/diagnosis
    Language English
    Publishing date 2020-09-18
    Publishing country United States
    Document type Case Reports ; Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 80015-6
    ISSN 1555-7162 ; 1873-2178 ; 0002-9343 ; 1548-2766
    ISSN (online) 1555-7162 ; 1873-2178
    ISSN 0002-9343 ; 1548-2766
    DOI 10.1016/j.amjmed.2020.07.039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Prevalence of hepatitis C in patients with non-affective psychotic disorders.

    Cuadrado, Antonio / Cabezas, Joaquín / Llerena, Susana / Nieves Salceda, Juan Francisco / Fortea, José Ignacio / Crespo-Facorro, Benedicto / Crespo, Javier

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva

    2020  Volume 112, Issue 7, Page(s) 550–554

    Abstract: Introduction: the goal of this study was to determine the prevalence of hepatitis C virus (HCV) infection in patients with non-affective psychotic disorders and to compare it with population-based data.: Material and methods: an observational study ... ...

    Abstract Introduction: the goal of this study was to determine the prevalence of hepatitis C virus (HCV) infection in patients with non-affective psychotic disorders and to compare it with population-based data.
    Material and methods: an observational study was performed that measured anti-HCV antibodies (HCV-RNA in case of seropositivity) in 425 serum samples from patients with non-affective psychosis. Eight patients were positive for anti-HCV (1.9 %) and five had detectable HCV-RNA (1.2 %). The prevalence of viremia was significantly higher than in the general population (OR: 5.4; 95 % CI: 1.9-14.6).
    Conclusions: patients with non-affective psychotic disorder have a higher prevalence of active infection than that of the general population and should undergo systematic screening.
    MeSH term(s) Hepacivirus/genetics ; Hepatitis C/epidemiology ; Hepatitis C Antibodies ; Humans ; Prevalence ; Psychotic Disorders/epidemiology
    Chemical Substances Hepatitis C Antibodies
    Language English
    Publishing date 2020-08-04
    Publishing country Spain
    Document type Journal Article ; Observational Study
    ZDB-ID 1070381-0
    ISSN 1130-0108 ; 0212-7512
    ISSN 1130-0108 ; 0212-7512
    DOI 10.17235/reed.2020.7278/2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top